BRCA1/2 test results impact risk management attitudes, intentions, and uptake
Suzanne C. O’Neill(Georgetown University), Marc D. Schwartz(Guardia Civil), Karen Brown(University of Leicester), Claudine Isaacs(Georgetown University), Kristi D. Graves(Georgetown University), Heiðdís Valdimarsdóttir(Reykjavík University), Sharon Hecker(Georgetown University), Beth N. Peshkin(Georgetown University), Karen Hurley(Icahn School of Medicine at Mount Sinai), Tiffani A. DeMarco(Georgetown University)
Cited by 25
Related Papers
Prostate Cancer Screening in the Randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: Mortality Results after 13 Years of Follow-up
|JNCI Journal of the National Cancer Institute|2012|1.1k
Colorectal-Cancer Incidence and Mortality with Screening Flexible Sigmoidoscopy
|New England Journal of Medicine|2012|1k
Effect of Pembrolizumab Plus Neoadjuvant Chemotherapy on Pathologic Complete Response in Women With Early-Stage Breast Cancer
|JAMA Oncology|2020|707
Screening by Chest Radiograph and Lung Cancer Mortality
|JAMA|2011|659
The Group-Based Medical Mistrust Scale: psychometric properties and association with breast cancer screening
|Preventive Medicine|2003|495